Repare Therapeutics Inc. (RPTX)
NASDAQ: RPTX
· Real-Time Price · USD
1.58
0.02 (1.28%)
At close: Aug 15, 2025, 3:59 PM
1.57
-0.63%
After-hours: Aug 15, 2025, 04:04 PM EDT
Repare Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 53.73M | 54.55M | 106.95M | 120M | 68.68M | 97.86M | 51.13M | 56.28M | 166.67M | 137.1M | 131.83M | 120.51M | 8.24M | 7.84M | 7.6M | 858K | 580K | 301K |
Cost of Revenue | 79.2M | 79.69M | 79M | 1.44M | 12.2M | 12.76M | 13.24M | 13.75M | 34.29M | 34.31M | 59.79M | 59.76M | 53.88M | 73.02M | 63.07M | 73.18M | 57.91M | 46.65M |
Gross Profit | 38.71M | 39.04M | 92.13M | 105.13M | 56.49M | 85.1M | 37.89M | 42.53M | 132.38M | 102.79M | 72.04M | 60.75M | -45.64M | -65.17M | -55.47M | -72.32M | -57.33M | -46.35M |
Operating Income | -116M | -135.53M | -93.53M | -93.33M | -95.37M | -70.31M | -115.81M | -104.99M | 6.83M | -19.65M | -19.8M | -28.9M | -133.98M | -121.91M | -108.66M | -97M | -79.41M | -65.06M |
Interest Income | 7.3M | 8.96M | 10.39M | 11.48M | 12.28M | 12.88M | 13.33M | 13.16M | 11.87M | 8.93M | 5.63M | 2.8M | 830K | 324K | 259K | 239K | 342K | 304K |
Pretax Income | -108.62M | -126.31M | -82.85M | -81.74M | -83M | -57.65M | -102.76M | -91.97M | 18.72M | -10.5M | -13.9M | -25.97M | -133.09M | -121.76M | -108.59M | -96.7M | -78.74M | -63.75M |
Net Income | -109.86M | -127.89M | -84.69M | -84.05M | -68.52M | -45.69M | -93.8M | -97.42M | -3.08M | -29.23M | -29.05M | -25.68M | -132.03M | -120.25M | -106.91M | -93.88M | -76.74M | -62.23M |
Selling & General & Admin | 26.43M | 28.71M | 29.68M | 31.91M | 33.34M | 33.74M | 33.65M | 33.05M | 33.09M | 32.31M | 32.56M | 32.26M | 30.95M | 29.75M | 26.21M | 23.37M | 20.77M | 17.4M |
Research & Development | 88.7M | 103.74M | 115.94M | 124.66M | 128.97M | 133.43M | 132.79M | 128.22M | 126.75M | 124.44M | 119.07M | 117.15M | 111.27M | 100M | 90.05M | 74.49M | 59.22M | 47.97M |
Other Expenses | -76.95M | -74.67M | -77.94M | 1.53M | -32.71M | -32.73M | -32.75M | -32.74M | -65K | -50K | -43K | -76K | -46K | -42K | -41K | -27K | -24K | -21K |
Operating Expenses | 38.17M | 57.78M | 67.68M | 158.09M | 129.59M | 134.45M | 133.73M | 128.56M | 159.84M | 156.75M | 151.63M | 149.41M | 142.22M | 129.75M | 116.26M | 97.86M | 79.99M | 65.36M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | -116K | -116K | -116K | -116K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 116.24M | 136.34M | 146.74M | 159.59M | 163.79M | 168.17M | 166.94M | 161.27M | 159.84M | 156.75M | 151.63M | 149.41M | 142.22M | 129.75M | 116.26M | 97.86M | 79.99M | 65.36M |
Income Tax Expense | 503K | 841K | 1.84M | 2.31M | -14.48M | -11.95M | -8.97M | 5.46M | 21.81M | 18.73M | 15.15M | -293K | -1.05M | -1.51M | -1.68M | -2.82M | -2.01M | -1.51M |
Shares Outstanding (Basic) | 42.92M | 42.59M | 42.41M | 42.45M | 42.45M | 42.23M | 42.14M | 42.1M | 42.09M | 42.04M | 42.04M | 41.95M | 41.9M | 41.86M | 39.99M | 37.12M | 37.04M | 36.92M |
Shares Outstanding (Diluted) | 42.92M | 42.59M | 42.41M | 42.45M | 42.45M | 44.02M | 42.14M | 42.1M | 42.09M | 42.04M | 42.04M | 44.18M | 41.9M | 41.86M | 40.17M | 37.12M | 37.04M | 36.92M |
EPS (Basic) | -2.58 | -3.01 | -1.99 | -1.99 | -1.63 | -1.09 | -2.23 | -2.31 | -0.06 | -0.69 | -0.69 | -0.65 | -3.28 | -3.08 | -2.83 | -2.53 | -2.07 | -3.81 |
EPS (Diluted) | -2.58 | -3.01 | -2 | -2 | -1.64 | -1.1 | -2.23 | -2.31 | -0.15 | -0.78 | -0.78 | -0.73 | -3.27 | -3.07 | -2.82 | -2.53 | -2.07 | -3.81 |
EBITDA | -112.66M | -130.45M | -87.94M | -90.23M | -93.78M | -68.72M | -114.27M | -103.09M | 8.71M | -17.75M | -17.82M | -27.01M | -132.2M | -120.24M | -107.19M | -95.61M | -78.18M | -64.04M |
EBIT | -111.36M | -128.62M | -89.88M | -92.22M | -95.79M | -70.73M | -116.22M | -104.99M | 6.83M | -19.65M | -19.8M | -28.9M | -133.98M | -121.91M | -108.66M | -97M | -79.41M | -65.07M |
Depreciation & Amortization | 3.15M | 2.61M | 1.92M | 1.97M | 1.99M | 2.56M | 3.04M | 3.55M | 3.54M | 3.55M | 3.63M | 3.61M | 3.99M | 3.71M | 3.34M | 2.64M | 1.98M | 1.39M |